DVA: DaVita HealthCare Partners EV/EBITDA Multiple

Brandmark of DaVita (DVA)

DaVita Inc. (DVA) dominance in the dialysis segment and its powerful lobbying create insurmountable barriers, which is confirmed by the precise GURU.Markets service chart based on the EV/EBITDA multiple valuation. The difficulty of network expansion due to equipment costs and the expertise of Javier Rodriguez's team drive the price action, while the value of 8.92 shows the latest reading, helping to determine the asset's risk-reward balance.

DaVita Corp - DVA EV/EBITDA Multiple (period 11/23/2025 - 11/14/2026)

Analytical breakdowns for DaVita Inc.

- stock price and consensus target price:
Stock Quotes DaVita Inc|DVA - Analyst Forecast Prices
- market capitalization information:
Market Capitalization DaVita Corp|DVA - Business Value
- issuer book value statistics:
Book Value per Share DaVita|DVA - Book Capitalization|Market Cap to Net Assets Ratio davita.com|DVA - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital DaVita Inc.|DVA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio DaVita|DVA - Company Cumulative Indebtedness|Debts to Book Capitalization DaVita Corp|DVA - Company Long-Term Debts|Company Current Liabilities DaVita|Quick Ratio davita.com
- financial results and valuation multiples details:
DVA - Net Financial Result|Expected Profit DaVita Inc.|DVA - Price to Earnings Multiple|Forward P/E Multiple DaVita Inc.|DVA - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio DaVita Corp|DVA - Operating income before deduction of amortization|Net earnings per share (EPS TTM) DaVita|DVA - Earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months davita.com|DVA - Earnings per share growth in current year|Earnings growth forecast for next year DaVita Inc.
- total revenue and sales volume data:
DVA - Revenue and Sales Volume|Company Future Sales Volume DaVita Inc|DVA - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio DaVita Corp
General company analysis:DaVita Inc DVA
Product sample of DaVita HealthCare Partners

For the defensive asset DaVita Inc. (DVA), which benefits from guaranteed demand for dialysis, it is critical to distinguish market volatility from the business's intrinsic value. The company's EV/EBITDA ratio on the GURU.Markets chart compares the total enterprise value with operating profit before depreciation and taxes. This metric neutralizes the impact of debt load and accounting methods for asset write-downs. Investors should utilize this indicator to determine a fair entry price given the stable cash flows.

Competitors of DaVita Inc.

HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Health)|Fresenius Medical Care - EV/EBITDA Multiple|SOLV (solventum.com) - Enterprise Value to Operating Income Before Depreciation|EHC: EV/EBITDA Multiple|Universal Health Services, Inc. (UHS) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio RDNT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OPCH|EV/EBITDA Multiple SGRY|Total Company Value to Operating Income Before Depreciation Ratio premierinc.com|National Vision - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PGNY (Progyny Inc)|Ardent Health Partners Inc - EV/EBITDA Multiple|SEM - EV/EBITDA Multiple|ASTH (Astrana Health, Inc.) - Enterprise Value to EBITDA Ratio|Pediatrix Medical Group - Business Value to Operating Income Before Depreciation|USPH (US Physical Therapy) - EV/EBITDA Multiple|Pennant Group (PNTG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Organogenesis Inc. (ORGO)|Nutex Health Hospitals - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUNA (Auna SA)|SBC - Enterprise Value to EBITDA Ratio|EOLS: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio CHS CYH|SKIN: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation MDWD|Enterprise Value to EBITDA Ratio BTMD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization JYNT|EV/EBITDA Multiple DCGO|EV/EBITDA Multiple p3hp.org (PIII)|Gain Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio EUDA (euda.com)|BMGL - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CLGN (CollPlant Biotechnologies)|CUPR: EV/EBITDA Multiple|Company Value to EBITDA Concord Medical Services Holdings (CCM)|AMS (American Shared Hospital Services, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple MEDIROM Corp|Enterprise Value to EBITDA Ratio ALBT (Avalon GloboCare)|Enterprise Value to Operating Income Before Depreciation Ratio DHAI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carmell Therapeutics XAGE|NIVF - Enterprise Value to EBITDA Ratio|ATI Physical Therapy Corp - EV/EBITDA Multiple|Company Value to EBITDA CareMax, Inc|Kindly MD, Inc. (KDLY) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MODV|Enterprise Value to EBITDA Ratio NVOS|SSY (SunLink Health Systems, Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple BACK